MLTX 株価推移チャート
MLTX 株価予測
MoonLake Immunotherapeutics
$0
0%
$0
終値： May 01, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：May 01, 20:00:00 GMT-4
戻る
MoonLake Immunotherapeutics (MLTX) 株価予測
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
MLTXとは何ですか？
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
